Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease

Brain

Volumn 122, Issue 2, 1999, Pages 247-253

  Love, S ^a   Barber, R ^a   Wilcock, G K ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; DNA damage; NAD+ ADP ribosyltransferase; Oxidative stress; Poly(ADP ribose) polymerase

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEAR PROTEIN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; AUTOPSY; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN CHEMISTRY; FEMALE; FRONTAL LOBE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEURONS; NUCLEAR PROTEINS; OXIDATIVE STRESS; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; TAU PROTEINS; TEMPORAL LOBE;

EID: 0032901904     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.2.247     Document Type: Article

References (49)

1. Aoufouchi S. Monoclonal antibodies: A4.3.4, A6.4.12, B5.3.9, B15.4.13 anti-poly(ADP-ribose) polymerase. Hybridoma 1997; 16: 583.
2. Benzi G, Moretti A. Are reactive oxygen species involved in Alzheimer's disease? [see comments] Neurobiol Aging 1995; 16: 661-74. Comment in: Neurobiol Aging 1995; 16: 675-83.
3. Benzi G, Moretti A. Are reactive oxygen species involved in Alzheimer's disease? [see comments] Neurobiol Aging 1995; 16: 661-74. Comment in: Neurobiol Aging 1995; 16: 675-83.
4. Birkmayer JG. Coenzyme nicotinamide adenine dinucleotide: new therapeutic approach for improving dementia of the Alzheimer type. Ann Clin Lab Sci 1996; 26: 1-9.
5. Choi DW. Glutamate receptors and the induction of excitotoxic neuronal death. [Review]. Prog Brain Res 1994; 100: 47-51.
6. de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, et al. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 1997; 94: 7303-7.
7. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB. et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 1995; 6: 1053-7.
8. Eliasson MJL, Sampei K, Mandir AS, Hum PD, Traystman RJ, Bao J, et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 1997; 3: 1089-95.
9. Elliott RB, Pilcher CC, Fergusson DM, Stewart AW. A population based strategy to prevent insulin-dependent diabetes using nicotinamide. J Pediatr Endocrinol Metab 1996; 9: 501-9.
10. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 1997; 17: 1143-51.
11. Fivenson DP, Kimbrough TL. Lichen planus pemphigoides: combination therapy with tetracycline and nicotinamide. J Am Acad Dermatol 1997; 36: 638-40.
12. Gale EA. Molecular mechanisms of -cell destruction in IDDM: the role of nicotinamide. [Review]. Hormone Res 1996; 45 Suppl 1: 39-43.
13. Good PF, Werner P, Hsu A, Olanow CW, Perl DP. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996; 149: 21-8.
14. Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM. Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40) in cultured hippocampal neurons. Exp Neurol 1995; 131: 193-202.
15. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M. et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 1995: 65: 2146-56.
16. Hornschuh B, Hamm H, Wever S, Hashimoto T, Schroder U, Brocker EB, et al. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol. J Am Acad Dermatol 1997; 36: 101-3.
17. Jonas WB, Rapoza CP, Blair WF. The effect of niacinamide on osteoarthritis: a pilot study. Inflamm Res 1996; 45: 330-4.
18. Kawamitsu H, Hoshino H, Okada H, Miwa M, Momoi H, Sugimura T. Monoclonal antibodies to poly(adenosine diphosphate ribose) recognize different structures. Biochemistry 1984; 23: 3771-7.
19. nbKeller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 1997; 69: 273-84.
20. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (Berl) 1995; 89: 35-41.
21. Lautier D, Poirier D, Boudreau A, Alaoui Jamali MA, Castonguay A, Poirier G. Stimulation of poly(ADP-ribose) synthesis by free radicals in C3H10T1/2 cells: relationship with NAD metabolism and DNA breakage. Biochem Cell Biol 1990; 68: 602-8.
22. Love S, Barber R, Wilcock GK. Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man. Neuroreport 1998; 9: 955-9.
23. Love S, Barber R, Wilcock GK. Neuronal accumulation of poly(ADP-ribose) after brain ischaemia. Neuropathol Appl Neurobiol. In press 1998.
24. Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 1997; 68: 2061-9.
25. Mark RJ, Blanc EM, Mattson MP. Amyloid β-peptide and oxidative cellular injury in Alzheimer's disease. [Review]. Mol Neurobiol 1996; 12: 211-24.
26. Mirra SS, Heyman A, McKeel D, Sumi SM, Grain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86.
27. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists [see comments]. [Review]. Arch Pathol Lab Med 1993; 117: 132-44. Comment in: Arch Pathol Lab Med 1993; 117: 129-31.
28. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists [see comments]. [Review]. Arch Pathol Lab Med 1993; 117: 132-44. Comment in: Arch Pathol Lab Med 1993; 117: 129-31.
29. Pappolla MA, Chyan Y-J, Omar RA, Hsiao K, Perry G, Smith MA, et al. Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease. A chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 1998; 152: 871-7.
30. Poskitt L, Wojnarowska F. Treatment of cicatricial pemphigoid with tetracycline and nicotinamide. Clin Exp Dermatol 1995; 20: 258-9.
31. Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, et al. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia 1995; 38: 848-52.
32. Pozzilli P, Browne PD, Kolb H. Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. The Nicotinamide Trialists. Diabetes Care 1996; 19: 1357-63.
33. Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, et al. Vitamin E and nicotinamide have similar effects in maintaining residual β-cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study). Eur J Endocrinol 1997; 137: 234-9.
34. Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature 1992; 356: 356-8.
35. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997; 68: 2092-7.
36. Schipper HM, Cisse S, Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 1995; 37: 758-68.
37. Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 1994; 145: 42-7.
38. Smith MA, Sayre LM, Monnier VM, Perry G. Radical AGEing in Alzheimer's disease [see comments]. [Review]. Trends Neurosci 1995; 18: 172-6. Comment in: Trends Neurosci 1995; 18: 341-2.
39. Smith MA, Sayre LM, Monnier VM, Perry G. Radical AGEing in Alzheimer's disease [see comments]. [Review]. Trends Neurosci 1995; 18: 172-6. Comment in: Trends Neurosci 1995; 18: 341-2.
40. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997; 17: 2653-7.
41. Su JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 1994; 5: 2529-33.
42. Szabó C, Ohshima H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1997; 1: 373-85.
43. Szabó C, Zingarelli B, O'Connor M, Salzman AL. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 1996; 93: 1753-8.
44. Takahashi K, Greenberg JH, Jackson P, Maclin K, Zhang J. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1997; 17: 1137-42.
45. Troncoso JC, Sukhov RR, Kawas CH, Koliatsos VE. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. J Neuropathol Exp Neurol 1996; 55: 1134-42.
46. Weinfeld M, Chaudhry MA, D'Amours D, Pelletier JD, Poirier GG, Povirk LF, et al. Interaction of DNA-dependent protein kinase and poly(ADP-ribose) polymerase with radiation-induced DNA strand breaks. Radiat Res 1997; 148: 22-8.
47. Yan SD, Chen X, Schmidt AM, Brett J, Godman G, Zou YS, et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 1994; 91: 7787-91.
48. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity [see comments]. Science 1994; 263: 687-9. Comment in: Science 1994; 265: 722-3.
49. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity [see comments]. Science 1994; 263: 687-9. Comment in: Science 1994; 265: 722-3.